This review aims to investigate the erythropoiesis process, pathophysiology, genotype-phenotype correlation, diagnosis, and treatment modalities in Hb H/CS disease, providing insights that could lay the foundational framework for the advancement of tailored therapy for the condition. The gene discussed is GSTM1; the disease is Cowden syndrome 1.